This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
MyBioSource
product type :
antibody
product name :
Rabbit anti BMP-4 Polyclonal
catalog :
MBS551014
quantity :
0.1 mg
price :
280 USD
clonality :
polyclonal
host :
rabbit
conjugate :
BMP
reactivity :
human, mouse, rat
application :
western blot, ELISA, immunohistochemistry, enzyme immunoassay
product information
catalog number :
MBS551014
products type :
Antibody
products full name :
Rabbit anti BMP-4 Polyclonal
products short name :
BMP-4
products name syn :
Rabbit anti BMP-4 Polyclonal purified; Bone Morphogenetic protein ; bmp-4; bmp4; polyclonal; PAb
other names :
bone morphogenetic protein 4 preproprotein; Bone morphogenetic protein 4; Bone morphogenetic protein 2B
products gene name :
BMP-4
other gene names :
BMP4; BMP2B; DVR4; BMP-4; BMP-2B
uniprot entry name :
BMP4_HUMAN
clonality :
Polyclonal
isotype :
IgG
host :
Rabbit
reactivity :
Human, Mouse, Rat
sequence length :
408
purity :
Serum IgG fraction was purified by Protein G affinity chromatography.
form :
Lyophilized from sterile filtered PBS solution at a concentration of 1mg/ml.
storage stability :
The lyophilized antibody is stable for at least 1 year from date of receipt at -20 degree C. Upon reconstitution, this antibody can be stored in working aliquots at 2 degree - 8 degree C for one month, or at -20 degree C for six months without detectable loss of activity. Avoid repeated freeze/thaw cycles. Shelf Life: >12 months
tested application :
Western Blot (WB), IHC (Immunohistochemistry), ELISA (EIA)
app notes :
ELISA: Use at a concentration range of 1-2ug/ml. Western blot:A suitable range of concentrations of this antibody for WB detection is 2-10 ug/ml. IHC: A suitable range of concentrations of this antibody for IHC is 2-10 ug/ml.
other info1 :
Source Note: Polyclonal BMP-4 antibody was produced from sera of rabbits immunized with synthetic protein containing BMP-4 antigenic determinants.
other info2 :
Reconstitution: A quick spin of the vial followed by reconstitution in distilled water. This solution can then be diluted into other buffers
products categories :
Polyclonal
products description :
BMPs are proteins that act to induce the differentiation of mesenchymal-type cells into chondrocytes and osteoblasts before initiating bone formation. They promote the differentiation of cartilage-forming cells and bone-forming cells near sites of fractures but also at ectopic locations. Some of the proteins induce the synthesis of alkaline phosphatase and collagen in osteoblasts. Some BMPs act directly on osteoblasts and promote their maturation while at the same time suppressing myogenous differentiation. Other BMPs promote the conversion of typical fibroblasts into chondrocytes and are capable also of inducing the expression of an osteoblast phenotype in non-osteogenic cell types. Intracellular signaling following engagement of receptors for some BMP proteins has been shown to involve the action of SMAD proteins. BMP4 and BMP7 have been shown to be involved also in the differentiation of sympathetic neurons. They enhance the formation of adrenergic sympathetic neurons in cultures of neural crest cells.
products references :
smad, pi3k/akt, and wnt-dependent signaling pathways are involved in BMP-4 -induced esc self-renewal . Stem Cells, Aug 2009; 27: 1858 - 1868. molecular interaction of BMP-4 , tgf- , and estrogens in lactotrophs: impact on the prl promoter . Mol. Endocrinol., Jul 2009; 23: 1102 - 1114. suppression of vegf expression and lesion size in laser-induced cnv in a mouse model overexpressing BMP-4 . Invest. Ophthalmol. Vis. Sci., Apr 2009; 50: 1193. altered shear stress stimulates upregulation of endothelial vcam-1 and icam-1 in a BMP-4 and tgf- 1 dependent pathway . Arterioscler Thromb Vasc Biol, Feb 2009; 29: 254 - 260. the bone morphogenetic protein (bmp) -4 is involved in the regulation of human megakaryocytic differentiation during thrombopoietin signaling. . Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 1339.
ncbi gi num :
157276593
ncbi acc num :
NP_001193.2
ncbi gb acc num :
NM_001202.3
uniprot acc num :
P12644
ncbi mol weight :
46,555 Da
ncbi pathways :
Adipogenesis Pathway 198832!!Basal Cell Carcinoma Pathway 83113!!Basal Cell Carcinoma Pathway 525!!Glypican 3 Network Pathway 138084!!Heart Development Pathway 198802!!Hedgehog Signaling Pathway 83063!!Hedgehog Signaling Pathway 474!!Pathways In Cancer 83105!!TGF Beta Signaling Pathway 198810!!TGF-beta Signaling Pathway 83064
uniprot summary :
Function: Induces cartilage and bone formation. Also act in mesoderm induction, tooth development, limb formation and fracture repair. Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction . By similarity. Subunit structure: Homodimer; disulfide-linked . By similarity. Interacts with GREM2. Part of a complex consisting of TWSG1 and CHRD. Interacts with the serine proteases, HTRA1 and HTRA3; the interaction with either inhibits BMP4-mediated signaling. The HTRA protease activity is required for this inhibition . By similarity. Interacts with SOSTDC1. Ref.5. Subcellular location: Secreted extracellular space extracellular matrix. Tissue specificity: Expressed in the lung and lower levels seen in the kidney. Present also in normal and neoplastic prostate tissues, and prostate cancer cell lines. Involvement in disease: Microphthalmia, syndromic, 6 (MCOPS6) [MIM:607932]: A disease characterized by microphthalmia/anophthalmia associated with facial, genital, skeletal, neurologic and endocrine anomalies. Microphthalmia is a disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.7Non-syndromic orofacial cleft 11 (OFC11) [MIM:600625]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.9. Sequence similarities: Belongs to the TGF-beta family.
size :
0.1 mg
price :
280 USD
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!